PhRMA presents research at ISPOR 2022

Last week at the ISPOR annual international meeting, PhRMA partnered with multiple organizations committed to advancing value assessment research and methods. We worked with a range of academics, researchers and key stakeholders to drive constructive conversations around value assessment research that examines drugs and other treatments and services across the entire health care system; incorporating outcomes that matter to patients; and tackling diversity and health equity. PhRMA-sponsored research included:
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: The Value Collaborative Value Assessment Source Type: news